Browsing Category
Pharma Industry News
4763 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Arcturus Therapeutics’ ARCT-032 gets EU’s orphan medicinal product designation for cystic fibrosis
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a leading global clinical-stage messenger RNA medicines company, has achieved a significant…
February 22, 2024
FDA approves first generic RECTIV ointment by Cosette Pharmaceuticals
In a landmark move for the pharmaceutical industry, Cosette Pharmaceuticals, Inc. has received approval from the U.S. Food…
February 22, 2024
Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML
Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology,…
February 22, 2024
SkinBioTherapeutics partners with Umesh Modi Group for Dermatonics launch in AMEA
SkinBioTherapeutics plc (AIM: SBTX), a leading life science company focused on skin health, has announced a strategic partnership…
February 21, 2024
Olatec Therapeutics set to launch dapansutrile Phase 2 trial in Parkinson’s disease
Olatec Therapeutics, Inc. (Olatec), a leader in the field of selective NLRP3 inhibitors, has embarked on a journey…
February 20, 2024
LTR Pharma initiates pivotal study of SPONTAN nasal spray in erectile dysfunction
LTR Pharma Limited (ASX:LTP), a company dedicated to advancing men’s health, has proudly announced the commencement of patient…
February 19, 2024
Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research
Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with…
February 18, 2024
FDA approves Iovance’s AMTAGVI: A breakthrough in melanoma treatment
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a trailblazer in the field of biotechnology focused on developing novel polyclonal tumor…
February 18, 2024
Japan’s MHLW grants priority review for PADCEV and KEYTRUDA combo in urothelial cancer
In a significant development in the fight against urothelial cancer, Astellas Pharma Inc. announced that Japan’s Ministry of…
February 18, 2024
CASI Pharmaceuticals administers first FOLOTYN dose in China for PTCL treatment
In a significant stride toward addressing the critical medical needs of peripheral T-cell lymphoma (PTCL) patients in China,…
February 18, 2024